Definitive Contract 75A50120C00092
Award Date
5/18/20
Potential Completion Date
5/17/30
Potential Value
$918M
Awardee
Phlow Corp.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
AN17 - R&D- Medical: Biomedical (Commercialized)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Richmond, VA 23219, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,403,362,669.10 cost-plus-fixed-fee contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Product Development Gaithersburg Inc., a for-profit limited liability company manufacturing medical countermeasures and pharmaceuticals. The contract, which has a period of performance through September 29, 2026, is for the development of filovirus treatments. Emergent has received over $1.3...
This federal contract award is an Other Transaction Agreement between Global Life Sciences Solutions USA LLC and the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency. The $72,104,359.91 cost-sharing agreement is focused on expanding capacity for COVID-19 response and supporting public health emergencies, with a completion date of December 31, 2038. Global Life Sciences Solutions USA LLC, a for-profit limited liability company and wholly owned subsidiary...
This is a $19,763,563.00 cost-plus-fixed-fee delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract was awarded to Emergent Manufacturing Operations Baltimore LLC, a for-profit limited liability company and manufacturer of goods registered in the System for Award Management (SAM). The contract is part of the Centers for Innovation in Advanced...
The Department of the Air Force Materiel Command Aeronautical Systems Center awarded a definitive contract valued at $69.3 million to Continuus Pharmaceuticals, Inc. of Woburn, Massachusetts. The firm fixed price contract will support the Department of Health and Human Services' efforts to expand domestic pharmaceutical manufacturing capacity for three COVID-19 related drugs. Specifically, Continuus Pharmaceuticals will establish integrated continuous manufacturing facilities capable of annually...
This is a $23,109,340.68 cost-plus-fixed-fee delivery order awarded to Emergent Manufacturing Operations Baltimore LLC, a for-profit limited liability company manufacturer, by the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services. The contract is for the development of a plasma-derived polyclonal antibody-based COVID-19 therapeutic, under the Centers for Innovation in Advanced Development and Manufacturing program. No...
This is a firm fixed-price purchase order contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services (HHS), to Flexbiosys Inc., a small business manufacturer of pharmaceutical consumables. The contract, valued at $14,372,753.00, is to expand and accelerate Flexbiosys' domestic production capacity for single-use bags, tubing, and associated components to support COVID-19 vaccine development...
<p>This is a $205,003,103.62 cost-plus-fixed-fee definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Modex Therapeutics, Inc. to advance the development of potent, cross-reactive multispecific antibodies for the preparedness countermeasure of COVID-19 and seasonal and highly pathogenic avian influenza. The contract has an ultimate completion date of January 18, 2030. This award is not a set-aside contract.</p>
This is a definitive cost-sharing contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a leading provider of medical countermeasures, vaccines, and related products for pandemic preparedness and response. The $2,132,741,281.00 contract is for the construction of a vaccine manufacturing facility, with an ultimate completion date of January 31, 2034. Seqirus, a foreign-owned, for-profit...
This is a $228,598,975.00 definitive cost-sharing contract awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Janssen Research & Development, LLC. The contract was issued under ASPR's Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) focused on the advanced research and development of medical countermeasures against chemical, biological, radiological, nuclear, and...
This is a federal contract award made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), part of the U.S. Department of Health and Human Services (HHS), to Venatorx Pharmaceuticals Inc., a biopharmaceutical company specializing in the discovery and development of novel anti-infective therapeutics. The contract, valued at $147,481,537.00, does not have a set-aside designation and was awarded as a definitive, cost-sharing contract. The work under this contract focuses...